Navigation Links
AMDL, Inc. Completes Revision of Performance & Equity Incentive Compensation Plan
Date:1/8/2009

>

About AMDL:

Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs over 490 people in the U.S. and China.

Forward Looking Statements:

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL, Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. 

    AMDL Contact:
    Kristine Szarkowitz
    Director-Investor Relations
    kszarkowitz@amdl.com
    (Tel :) 206. 310.5323


'/>"/>
SOURCE AMDL, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report
2. AMDL, Inc. Selected as #1 Small-Cap Stock Pick for 2009
3. Ambulatory Services of America, Inc. Completes Purchase of Majority Interest in Rosa of Georgia, LLC
4. Kentucky Medical Services Foundation Completes Successful Charge Capture Technology Conversion
5. Escalon(R) Medical Corp. Completes Bolt-On Acquisition, Enhances Market Position in France and Expands Product Offering
6. Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis
7. Blue Cross and Blue Shield of Florida Completes Acquisition of Florida Health Care Plans
8. Hard To Treat Diseases (HTDS) Completes E Europe Merger
9. New Zealand Waynes New Resources Development Co., Ltd. Completes Reverse Merger to Go Public in the U.S.
10. Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
11. Smart Financial Credit Union Completes Key FCU Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... - TSO3 Inc. ("TSO3") (TSX: TOS) and 3M ... reached for 3M to be the exclusive supplier ... partnership with TSO3, an innovator in low temperature ... through the use of ozone, will include new ... global sales channel. This agreement, combined with recent ...
(Date:12/16/2009)... being presented with the Weatherhead 100 Upstart Award on December 3, ... Northeast Ohio and is a testament to hard work, commitment, innovation ... ... (PRWEB) December 16, 2009 -- Request A Test, Ltd. is ... on December 3, 2009. The Weatherhead 100 showcases the fastest ...
(Date:12/16/2009)... have announced a great addition to one of the most ... website at www.hallmark.co.uk/specialoccasions , customers can now personalise just about ... photos and then order as many copies of their design with ... ... December 16, 2009 -- Just in time for the Christmas rush ...
(Date:12/16/2009)... Help Hair Shake in all of the Florida Whole Foods store. ... ... Dr. Larry Shapiro, hair transplant and hair loss physician , is ... Help Hair Whey Protein Shake. Dr. Shapiro developed the all natural ... loss programs, working out and muscle building., , , , ,The Whole ...
(Date:12/15/2009)... The failure of the U.S. Senate ... costs, much less the more effective direct bulk ... example of how big industry controls the health ... drug amendment by Senator Dorgan (D-ND) was a ... pledge to allow Medicare to directly negotiate discounts ...
Breaking Medicine News(10 mins):Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 4Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 2Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 3Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 4Health News:Florida Whole Foods Stores to Carry Dr. Lawrence Shapiro's Help Hair Shake 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3
... in the US are worried about yet another bout of ... ,Rudy Bueno, the Chief of Mosquito Control of the ... people don't follow the precautionary measures. There is still a ... been affected by this disease. Not using repellants or going ...
... of Hurricane Katrina in New Orleans are still struggling ... be having the lions share of this. ,Accordingly, more ... the disaster said they had money problems because of the hurricane ... job or had to take a lower-paying job. The study ...
... Ridge, Ill. "Every second counts for anesthesia patients afflicted ... hyperthermia (MH)." According to research published in the ... Anesthetists, the intravenous administration of life-saving dantrolene sodium (DS) ... of warming the diluent that is used to prepare ...
... young women-under 55 is an aggressive disease that has to ... at the American Heart Association's (AHA) scientific forum on Quality ... in Washington, D.C., says that women under the age ... heart attack until it's too late. ,Ignoring those ...
... than 10 a week in spending money and who buy ... drinkers', a survey of over 10,000 teenagers reveals. ... studied the results of an alcohol questionnaire given anonymously to ... admitted to drinking alcohol, of which 38% binged, 24% drank ...
... per cent) of British women and a quarter of British men ... a result of excessive exposure to the sun, according to a ... highlight Sun Awareness Week, which kicks off Monday 7 May. ... meant that one in three Brits could not wear the clothes ...
Other Medicine News:Health News:Health Authorities Fear West Nile Season Again in US 2Health News:Hurricane Katrina Still Wrecking Lives - More So With Blacks 2Health News:Research Reveals Way to Speed Up Treatment of Deadly Malignant Hyperthermia 2Health News:Younger Women At Risk Of Heart Disease 2Health News:Younger Women At Risk Of Heart Disease 3Health News:Burnt Brits Don't Feel Hot 2
(Date:12/16/2009)... -- TechniScan, Inc. (OTC Bulletin Board: ... company engaged in the development and commercialization of ... that Joe Pepper, PhD, has been appointed to ... Chairman Ken Hungerford commented, "Joe has extensive experience ... GE OEC Medical and U-Systems, both of whom ...
(Date:12/16/2009)... Inc., a new clinical stage company developing innovative ... on its novel GFPA NMDA receptor modulators, today ... meeting showed that its lead compound GLYX-13 demonstrated ... of the CNS-related side effects seen with other ... also showed that GLYX-13,s antidepressant effects were evident ...
(Date:12/16/2009)... SAN DIEGO, Dec. 16 Optimer Pharmaceuticals, ... present at the 28th Annual J.P. Morgan Healthcare ... San Francisco on Wednesday, January 13, 2010. Michael ... will present at 2:30 p.m. Pacific Time (5:30 ... ,, A live audio webcast of this presentation ...
Breaking Medicine Technology:In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 2In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 5Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 6Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 6628 1Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 6628 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 6628 3China Biologic Products Approved to List on NASDAQ 6626 1China Biologic Products Approved to List on NASDAQ 6626 2China Biologic Products Approved to List on NASDAQ 6626 3ADVENTRX Pharmaceuticals Reports Additional Pre Clinical Data for ANX 514 6624 1ADVENTRX Pharmaceuticals Reports Additional Pre Clinical Data for ANX 514 6624 2ADVENTRX Pharmaceuticals Reports Additional Pre Clinical Data for ANX 514 6624 3
... Va., Oct. 18 CEL-SCI CORPORATION,(Amex: CVM ... Geert,Kersten, is a featured presenter at the International ... Maryland. Mr. Kersten will present on the "New ... 3:15 p.m. (Eastern Daylight,Time). In April 2007, ...
... Oct. 18 Access Pharmaceuticals, Inc.,(OTC Bulletin ... will be,presenting clinical and preclinical data on ... symposium of the American Association for,Cancer Research ... for Research and Treatment of Cancer (EORTC) ...
Other Medicine Technology:CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase 2Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference 2
US Autoflow Single Chamber Stackable Water-Jacketed CO2 Inc.w/ Humidity Display and Control...
3.0% Tryptone, 2.0% Yeast Extract, 1.0% MOPS free acid, 2.0% Glucose....
0.3% Beef extract, 0.5% Peptone, 0.5 % Lactose....
... The user-friendly Eppendorf Thermomixer R offers ... that require shaking, heating, and cooling. ... expanded its application and temperature control ... each accommodate 24 micro test tubes, ...
Medicine Products: